SI-BONE Inc
NASDAQ:SIBN

Watchlist Manager
SI-BONE Inc Logo
SI-BONE Inc
NASDAQ:SIBN
Watchlist
Price: 14.41 USD 0.14% Market Closed
Market Cap: 611.7m USD

SI-BONE Inc
Investor Relations

SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 352 full-time employees. The company went IPO on 2018-10-17. The firm is focused on the development of implantable devices used in the surgical treatment of sacro-pelvic anatomy. Its invasive surgical implant system, iFuse, is used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. Its iFuse Implant System includes a series of triangular titanium implants and the instruments developed to enable surgeons to perform the procedure. Its iFuse system, which includes its implants and instruments, is designed to address the shortcomings of alternative treatments, including open surgery, non-surgical management, and screw-based and other minimally invasive stabilization and fusion procedures. Its iFuse-3D design allows the surgeons to fill the implant with ground-up bone before implantation, which accelerates bone through-growth and biological fixation. The company also provides other technologies for its surgeons other than iFuse and iFuse-3D.

Show more
Loading

Earnings Calls

2025 Q1
Apr 17, 2025
Show Transcript
Previous
Next
Banner Corporation Reports Solid Q1 2025 Performance Amid Economic Uncertainty
2025 Q1
Apr 17, 2025

Banner Corporation achieved a net profit of $45.1 million, or $1.30 per share, in Q1 2025, slightly lower than $1.34 in the previous quarter. Core revenues grew to $160 million, up from $150 million year-over-year. Notably, core loan growth increased by 5%, and core deposits rose by 3%. The company anticipates a net interest margin (NIM) enhancement, forecasting a potential expansion to over 4% in 2025, driven by favorable loan repricing as the Federal Reserve pauses rate cuts. Despite some increases in loan delinquencies to 0.63%, credit quality remains manageable as Banner maintains a robust capital position.

Show Full Analysis

Management

Ms. Laura A. Francis MBA
CEO & Director
No Bio Available
Mr. Anshul Maheshwari
Chief Financial Officer
No Bio Available
Mr. Anthony J. Recupero
President of Commercial Operations
No Bio Available
Mr. Jeff Bertolini
Senior Vice President of Operations & Information Technology
No Bio Available
Dr. Scott A. Yerby
Senior VP of Engineering & CTO
No Bio Available
Saqib Iqbal
Director of FP&A and Investor Relations
No Bio Available
Mr. Michael A. Pisetsky J.D.
Chief Business & Legal Affairs Officer, Secretary and General Counsel
No Bio Available
Ms. Aimee Einstein
Vice President of People & Culture
No Bio Available
Dr. Daniel Joseph Cher
Senior Vice President of Clinical & Regulatory Affairs
No Bio Available
Dr. W. Carlton Reckling
Chief Medical Officer & VP of Medical Affairs
No Bio Available

Contacts

Address
CALIFORNIA
Santa Clara
471 El Camino Real Ste 101
Contacts
+14082070700.0
si-bone.com